0.25Open0.50Pre Close7 Volume139 Open Interest81.00Strike Price269.00Turnover36.56%IV1.51%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.45Extrinsic Value100Contract SizeAmericanOptions Type0.3585Delta0.1890Gamma168.93Leverage Ratio-0.2652Theta0.0013Rho60.56Eff Leverage0.0202Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet